Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.56 USD | +1.30% | +4.70% | -19.17% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 25.85M |
---|---|---|---|---|---|
Net income 2024 * | -41M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.44M | Net Debt 2025 * | 17.76M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.77
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.75% |
Latest transcript on Unity Biotechnology, Inc.
1 day | +1.99% | ||
1 week | +3.36% | ||
1 month | -6.10% | ||
3 months | -10.98% | ||
6 months | -22.61% | ||
Current year | -20.21% |
Managers | Title | Age | Since |
---|---|---|---|
Anirvan Ghosh
CEO | Chief Executive Officer | 60 | 20-03-29 |
Founder | 56 | 09-03-29 | |
Lynne Sullivan
DFI | Director of Finance/CFO | 58 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Berns
BRD | Director/Board Member | 57 | 18-03-26 |
Director/Board Member | 52 | 15-02-28 | |
Keith Leonard
CHM | Chairman | 62 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.56 | +1.30% | 39 156 |
24-04-30 | 1.54 | +1.99% | 27,357 |
24-04-29 | 1.51 | +0.67% | 43,612 |
24-04-26 | 1.5 | +1.35% | 38,503 |
24-04-25 | 1.48 | +0.68% | 17,141 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.21% | 25.85M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.16% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- UBX Stock